Literature DB >> 2431070

Free radical reduction by thioredoxin reductase at the surface of normal and vitiliginous human keratinocytes.

K U Schallreuter, M R Pittelkow, J M Wood.   

Abstract

Cell cultures of human keratinocytes contain membrane-associated thioredoxin reductase that is extremely active in reducing radicals on the outer plasma membrane. This enzyme activity was confirmed by its purification from cultures of stratified human keratinocytes by affinity column chromatography. The enzyme was assayed both in vivo and in vitro using a spin-labeled quaternary ammonium compound as the substrate, under saturating conditions in free radical substrate. Specific activities were determined by monitoring the sequential decrease in the amplitude of the electron spin resonance signal per unit of cell protein. The following properties were found: Cultures of adult stratified cells have approximately twice the thioredoxin reductase activity of neonatal cells. The enzyme is inhibited by thioprotein inhibitors (i.e., parachloromecuribenzoate and dinitrochlorobenzene). The activity is regulated by calcium concentrations of the cell culture medium. Stratified keratinocytes are half as active in medium containing 2 mM Ca++ compared with 0.1 mM Ca++ concentration. Product inhibition of the enzyme occurs with oxidized coenzyme NADP+ (i.e., 87% inhibition of enzyme activity over 30 min). The enzyme is heat stable at temperatures of 70 degrees C for 10 min. It is inactivated at 75 degrees C. A comparative study of thioredoxin reductase activity on stratified differentiated and undifferentiated rapidly growing cells was performed. Also, enzyme activity was quantitated for cultured keratinocytes isolated from vitiliginous and normal skin of the same donor. The results of this study, and the connection between this enzyme activity and UV-generated free radicals are reconciled in terms of the mechanism of action and metabolic activity of thioredoxin reductase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2431070     DOI: 10.1111/1523-1747.ep12456848

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

Review 1.  Thioredoxin reductase.

Authors:  D Mustacich; G Powis
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Dehydroascorbic acid uptake in a human keratinocyte cell line (HaCaT) is glutathione-independent.

Authors:  I Savini; S Duflot; L Avigliano
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

3.  Regulation of thioredoxin reductase by calcium in Hermansky-Pudlak syndrome.

Authors:  K U Schallreuter; M R Pittelkow
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

Review 4.  Highlights in pathogenesis of vitiligo.

Authors:  Ghada F Mohammed; Amal Ha Gomaa; Mohammed Saleh Al-Dhubaibi
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

5.  A possible mechanism of action for azelaic acid in the human epidermis.

Authors:  K U Schallreuter; J W Wood
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

6.  Defective calcium uptake in keratinocyte cell cultures from vitiliginous skin.

Authors:  K U Schallreuter; M P Pittelkow
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

7.  Defective calcium transport in vitiliginous melanocytes.

Authors:  K U Schallreuter-Wood; M R Pittelkow; N N Swanson
Journal:  Arch Dermatol Res       Date:  1996       Impact factor: 3.017

8.  Increased in vitro expression of beta 2-adrenoceptors in differentiating lesional keratinocytes of vitiligo patients.

Authors:  K U Schallreuter; J M Wood; M R Pittelkow; N N Swanson; V Steinkraus
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

9.  Catechol-O-methyltransferase in vitiligo.

Authors:  I C Le Poole; R M van den Wijngaard; N P Smit; J Oosting; W Westerhof; S Pavel
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

10.  Reversible inhibition of human thioredoxin reductase activity by cytotoxic alkyl 2-imidazolyl disulfide analogues.

Authors:  J E Oblong; E L Chantler; A Gallegos; D L Kirkpatrick; T Chen; N Marshall; G Powis
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.